Frank Partnoy: "Wait: The Art and Science of Delay" | WAMU 88.5 - American University Radio

WAMU 88.5 : The Diane Rehm Show

Filed Under:

Frank Partnoy: "Wait: The Art and Science of Delay"

American society is obsessed with speed, productivity and efficiency. We are told to never put off until tomorrow what can been done today. Quick decision making is considered a virtue, while procrastination is a sin. But University of San Diego law and finance professor Frank Partnoy says not so fast. In ancient Egypt and Rome, procrastination was thought to be useful and wise. Partnoy spent more than three years combing through scientific studies and interviewing experts in different fields to study the role of timing in decision making. He tells us why the longer we can wait before acting, the better.

Read An Excerpt

Excerpt from "Wait: The Art and Science of Delay" by Frank Partnoy. Copyright 2012 by Callum Roberts. Reprinted here by permission of PublicAffairs. All rights reserved.

NPR

'F' Is For Fraudster In A Family Novel For Our Modern Times

Daniel Kehlmann's F, about three brothers abandoned by their father, examines the detail of lives lived without integrity. It is brilliantly translated from the German by Carol Brown Janeway.
NPR

No. 1 Most Expensive Coffee Comes From Elephant's No. 2

A coffee entrepreneur claims his brew is different — and better — than the trendy civet poop coffee. And it starts with the idea that elephants, unlike humans or civets, are herbivores.
WAMU 88.5

Maureen McDonnell Didn't Give Special Treatment To Star Scientific, Witness Testifies

A defense witness in the corruption trail against former Virginia Governor Bob McDonnell and his wife, Maureen, says the former first lady often traveled the state promoting state businesses, countering the notion she gave special treatment to the company at the heart of the corruption trial.
NPR

The Momentum Of The Ice Bucket Challenge — And What It Means For ALS

A recent fundraising challenge has gone viral on social media, calling attention to research into Lou Gehrig's disease. Forbes contributor Dan Diamond discusses the state of that research.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.